52 research outputs found
The emerging role of Schlafen-11 (SLFN11) in predicting response to anticancer treatments: Focus on small cell lung cancer
No full textSmall cell lung cancer (SCLC) is characterized by a dismal prognosis. Many efforts have been made so far for identifying novel biomarkers for a personalized treatment for SCLC patients. Schlafen 11 (SLFN11) is a protein differently expressed in many cancers and recently emerged as a new potential biomarker. Lower expression of SLFN11 correlates with a worse prognosis in SCLC and other tumors. SLFN11 has a role in tumorigenesis, inducing replication arrest in the presence of DNA damage through the block of the replication fork. SLFN11 interacts also with chromatin accessibility, proteotoxic stress and mammalian target of rapamycin signalling pathway. The expression of SLFN11 is regulated by epigenetic mechanisms, including promoter methylation, histone deacetylation, and the histone methylation. The downregulation of SLFN11 correlates with a worse response to topoisomerase I and II inhibitors, alkylating agents, and poly ADP-ribose polymerase inhibitors in different cancer types. Some studies exploring strategies for overcoming drug resistance in tumors with low levels of SLFN11 showed promising results. One of these strategies includes the interaction with the Ataxia Telangiectasia and Rad3-related pathway, constitutively activated and leading to cell survival and tumor growth in the presence of low levels of SLFN11. Furthermore, the expression of SLFN11 is dynamic through time and different anticancer therapy and liquid biopsy seems to be an attractive tool for catching SLFN11 different expressions. Despite this, further investigations exploring SLFN11 as a predictive biomarker, its longitudinal changes, and new strategies to overcome drug resistances are needed
Effects of sound exposure on fish
No full textreservedEffetti dell'esposizione sonora sui pesci. presentazione della problematica principale, inquinamento acustico sottomarino. analisi di diversi casi di studio riguardanti Halobatrachus didactylus fornendo una visione completa delle conseguenze a partire dall'interferenza nell'emissione dei richiami, alla mortalità embrionale e all'aumento dei livelli di stress fisiologico. sintesi delle conclusioni dei diversi casi di studio e potenziali applicazioni del modello preso in esame. presentazione delle misure di compensazione in uso
Rumi. Vita e opere. Traduzioni dal Masnavi Ma'navi
No full textL'articolo contiene un'ampia introduzione alla vita e all'opera di Jalaloddin Rumi (con un focus specifico sul Masnavi Ma'navi), seguita dalla traduzione dall'originale persiano di quattro lunghi brani del Masnavi Ma'navi, nonché dei versi introduttivi denominati 'Il libro del flauto'. Le traduzioni sono precedute da una nota che esplicita il tema dottrinale oggetto del brano e corredate da estese note esplicative della terminologia sufi presente nei testi scelti
Clinical-pathological characterization and identification of predictive and prognostic biomarkers in patients with pleural mesothelioma: a single-center retrospective-prospective study
No full textopenPresupposti dello studio: Il mesotelioma pleurico è una neoplasia rara, principalmente dovuta all’esposizione all’asbesto e associata a prognosi infausta. La combinazione di chirurgia e chemioterapia con sali di platino e pemetrexed, in fase neoadiuvante o adiuvante, costituisce il trattamento standard per pazienti con malattia resecabile. Per i pazienti con malattia non resecabile, è prevista una prima linea di terapia con platino e pemetrexed in caso di istologia epitelioide, mentre gli inibitori del checkpoint immunitario hanno migliorato le prospettive di sopravvivenza negli istotipi non epitelioidi. L’identificazione di biomarcatori con valore predittivo e prognostico potrebbe ottimizzare la stratificazione dei pazienti e la gestione terapeutica.
Scopo dello studio: L’obiettivo primario è descrivere le caratteristiche clinico-patologiche di una coorte di pazienti affetti da mesotelioma pleurico, analizzandone la presentazione clinica e l’iter diagnostico-terapeutico. L’obiettivo secondario è l’individuazione di biomarcatori tissutali e circolanti e l'analisi della correlazione di quest’ultimi con gli outcome clinici.
Materiali e metodi: E' uno studio monocentrico retrospettivo-prospettico che ha considerato 105 pazienti affetti da mesotelioma pleurico trattati secondo pratica clinica. Di 21 pazienti sono stati analizzati i marcatori tissutali su campioni bioptici attraverso pannelli per immunofluorescenza multipla, nell’ambito del trial Imaging-Meso. 31 pazienti sono stati sottoposti alla valutazione delle citochine circolanti mediante tecnologia Multiplex Luminex, all’interno dello studio ICE-M2. Le analisi statistiche sono state eseguite tramite il software IBM SPSS Statistics (versione 30).
Risultati: Dei 105 pazienti arruolati, 42 (40%) sono stati sottoposti a trattamento radicale e 56 (53,3%) indirizzati a prima linea di terapia con chemioterapia o immunoterapia. L’OS mediana è risultata di 84 mesi per i pazienti con malattia resecabile e di 16,1 mesi per i pazienti con malattia non resecabile. La RFS mediana post trattamento radicale è stata di 16,5 mesi, mentre la PFS mediana in prima linea di terapia per malattia non resecabile è stata di 6 mesi. A T0 si sono osservati livelli più alti di IL-1β (p=0,039), IL-6 (p=0,001), IL-8 (p=0,007), TNFα (p=0,001) e IL-10 (p=0,015) nei pazienti con mesotelioma non epitelioide rispetto all’epitelioide. Con la chemioterapia i livelli di IL-8 (p=0,004) e IL-10 (p=0,001) sono aumentati. Con l’immunoterapia i livelli di IL-10 (p=0,006) sono aumentati e i livelli di IL-8 (p=0,002), di HGF (p=0,014) e dello score combinato di IL-6, IL-8 e HGF (p=0,04) sono diminuiti. Livelli più bassi di IL-6 (p=0,044) e IL-8 (p=0,025) correlavano con una migliore PFS dopo chemioterapia. Livelli più bassi di IL-6 (p=0,052) e TGF-β (p=0,015) correlavano con una migliore OS dopo chemioterapia. Si è riscontrato un trend tra un basso score combinato di IL-6, IL-8 e HGF e migliori PFS (p=0,055) e OS (p=0.083) dopo immunoterapia. L’istologia non epitelioide presentava maggiore espressione di FOXP3+ (p=0,032) e HLA- (p=0,018) e, nello stroma, di CD163+ (p=0,035); quella epitelioide più alti livelli di HLA+ (p=0,033) e, nello stroma, di CD20+ (p=0,034) e mostrava una minore distanza tra FOXP3+ e CD8+ (p=0,05). Una bassa espressione di FOXP3+ nello stroma(p=0,031) e una minore distanza tra CD8+ e CD20+ (p=0,019) correlavano con un’OS migliore. Alti livelli di CD20+ nello stroma mostravano una tendenza verso un’OS migliore (p=0,066) e correlavano con una PFS più lunga (p=0,004). Una minore distanza tra FOXP3+ e CD8+ correlava con una migliore PFS (p=0,019) e vi era un trend tra una minore distanza tra CD8+ e CD20+ e una migliore PFS (p=0,056).
Conclusioni: La chirurgia in centri specializzati migliora la sopravvivenza. Alcuni marcatori mostrano ruolo predittivo e prognostico.Background: Pleural mesothelioma is a rare tumor, mostly related to asbestos-exposure and associated with a poor prognosis. The standard treatment for patients with resectable disease consists of a multimodality approach, including surgery and platinum derivatives plus pemetrexed in either neoadjuvant or adjuvant setting. For patients with unresectable disease, first-line therapy involves platinum derivatives and pemetrexed for epithelioid histology, while the introduction of immune checkpoint inhibitors has improved survival outcomes in non-epithelioid subtypes. The identification of predictive and prognostic biomarkers could optimize patient stratification and therapeutic management.
Aim of the study: The primary objective of this study is to describe the clinical-pathological characteristics of a cohort of patients with pleural mesothelioma, analyzing their clinical presentation and diagnostic-therapeutic iter. The secondary objective is to identify tissue and circulating biomarkers and evaluate their correlation with clinical outcomes to determine their predictive and prognostic role.
Methods: This is a single-center retrospective-prospective study including 105 patients with pleural mesothelioma treated according to clinical practice. Tissue biomarkers were analyzed in biopsy samples from 21 patients using multiplex immunofluorescence panels within the Imaging-Meso trial. Levels of circulating cytokines were quantified in 31 patients using Multiplex Luminex technology during the ICE-M2 study. Statistical analyses were performed using IBM SPSS Statistics software (version 30).
Results: Among the 105 enrolled patients, 42 (40%) underwent radical treatment, while 56 (53.3%) received first-line therapy with either chemotherapy or immunotherapy. The median overall survival (OS) was 84 months for patients with resectable disease and 16,1 months for those with unresectable disease. The median relapse-free survival (RFS) after radical treatment was 16,5 months, whereas the median progression-free survival (PFS) during first-line therapy in unresectable disease was 6 months. At baseline (T0), higher levels of IL-1β (p=0.039), IL-6 (p=0.001), IL-8 (p=0.007), TNFα (p=0.001), and IL-10 (p=0.015) were observed in patients with non-epithelioid mesothelioma compared to epithelioid subtypes. Levels of IL-8 (p=0.004) and IL-10 (p=0.001) increased with chemotherapy. Levels of IL-10 (p=0.006) increased and levels of IL-8 (p=0.002), HGF (p=0.014), and the combined score of IL-6, IL-8, and HGF (p=0.04) decreased with immunotherapy. Lower IL-6 (p=0.044) and IL-8 (p=0.025) levels correlated with longer PFS after chemotherapy, whereas lower IL-6 (p=0.052) and TGF-β (p=0.015) levels correlated with longer OS after chemotherapy. A trend was observed between a lower combined score of IL-6, IL-8, and HGF and better PFS (p=0.055) and better OS (p=0.083) after immunotherapy. Non-epithelioid histology showed higher expression of FOXP3+ (p=0.032) and HLA- (p=0.018), as well as increased CD163+ (p=0.035) in the stroma. Epithelioid histology showed higher levels of HLA+ (p=0.033) and CD20+ (p=0.034) in the stroma, along with shorter distance between FOXP3+ and CD8+ (p=0.05). Lower FOXP3+ expression in the stroma (p=0.031) and shorter CD8+-CD20+ distance (p=0.019) correlated with longer OS. High stromal CD20+ levels showed a trend towards longer OS (p=0.066) and correlated with longer PFS (p=0.004). Shorter FOXP3+-CD8+ distance correlated with longer PFS (p=0.019), while a trend was observed between shorter CD8+-CD20+ distance and longer PFS (p=0.056).
Conclusions: Surgery may provide a survival advantage if performed on carefully selected patients in high-expertise centers. Some tissue and circulating biomarkers may show a predictive and prognostic role for pleural mesothelioma
Secondary prevention and treatment innovation of early stage non-small cell lung cancer: Impact on diagnostic-therapeutic pathway from a multidisciplinary perspective
No full text: Lung cancer (LC) is the leading cause of cancer-related death worldwide, mostly because the lack of a screening program so far. Although smoking cessation has a central role in LC primary prevention, several trials on LC screening through low-dose computed tomography (LDCT) in a high risk population showed a significant reduction of LC related mortality. Most trials showed heterogeneity in terms of selection criteria, comparator arm, detection nodule method, timing and intervals of screening and duration of the follow-up. LC screening programs currently active in Europe as well as around the world will lead to a higher number of early-stage Non Small Cell Lung Cancer (NSCLC) at the diagnosis. Innovative drugs have been recently transposed from the metastatic to the perioperative setting, leading to improvements in terms of resection rates and pathological responses after induction chemoimmunotherapy, and disease free survival with targeted agents and immune checkpoint inhibitors. The present review summarizes available evidence about LC screening, highlighting potential pitfalls and benefits and underlining the impact on the diagnostic therapeutic pathway of NSCLC from a multidisciplinary perspective. Future perspectives in terms of circulating biomarkers under evaluation for patients' risk stratification as well as a focus on recent clinical trials results and ongoing studies in the perioperative setting will be also presented
Memory in conflict. The incas in �El Calvario de Fuerte Quemado de Yocavil�, Northwest Argentina
No full textFil: Reynoso, Alejandra Daniela. Universidad de Buenos Aires. Facultad de Filosof�a y Letras. Museo Etnogr�fico "Juan B. Ambrosetti"; ArgentinaFil: Pratolongo, Ger�nimo Juan. Universidad de Buenos Aires. Facultad de Filosof�a y Letras. Museo Etnogr�fico "Juan B. Ambrosetti"; ArgentinaFil: Palamarczuk, Valeria. Consejo Nacional de Investigaciones Cient�ficas y T�cnicas. Universidad de Buenos Aires. Instituto de las Culturas; ArgentinaFil: Marchegiani, Marina In�s. Universidad de Buenos Aires. Facultad de Filosof�a y Letras. Museo Etnogr�fico "Juan B. Ambrosetti"; ArgentinaFil: Grimoldi, Mar�a Solange. Universidad de Buenos Aires. Facultad de Filosof�a y Letras. Museo Etnogr�fico "Juan B. Ambrosetti"; ArgentinaEste trabajo se propone estudiar la ocupaci�n incaica en El Calvario de Fuerte Quemado, importante poblado tard�o (siglos XI-XV d.C.) del valle de Yocavil, que al ser confundido con otro sitio cercano hab�a quedado relegado de las investigaciones regionales. En esta oportunidad, en base al relevamiento planialtim�trico del asentamiento, se analizan los distintos sectores con evidencias de ocupaci�n incaica y se presentan los resultados de las excavaciones realizadas en tres estructuras circulares de piedra, conocidas como ?torreones?. Se destaca la destrucci�n de una tumba local bajo alero para la construcci�n de uno de los torreones incaicos y la redepositaci�n de parte del contenido del entierro bajo su piso. Consideramos que estos datos ser�n relevantes para discutir las distintas interpretaciones sobre la relaci�n del estado incaico con las poblaciones locales. La destrucci�n de una estructura significativa para la memoria hist�rica local por parte de representantes del estado incaico, acontecimiento poco documentado arqueol�gicamente, pone de manifiesto el car�cter violento de la conquista imperial, m�s all� de las estrategias de negociaci�n con las elites locales.This work intends to study the Inca occupation in El Calvario de Fuerte Quemado, an important late village (XI-XV century AD) of the Yocavil valley, which, when confused with another nearby site, had been relegated from regional investigations. On this occasion, based on the planialtimetric survey of the settlement, the different sectors with evidence of Inca occupation are analyzed and the results of the excavations carried out in three circular stone structures, known as �torreones�, are presented. The destruction of a local tomb under a rocky ledge for the construction of one of the Inca towers and the redeposition of part of the burial content under its floor are stressed. We consider that these data will be relevant to discuss the different interpretations of the relationship between the Inca state and the local populations. The destruction of a significant structure for local historical memory by representatives of the Inca state, an event that has been hardly documented in archaeology, reveals -beyond the negotiation strategies with local elites- the violent character of the imperial conquest.Reynoso, A. D., Pratolongo, G., Palamarczuk, V., Marchegiani, M. y Grimoldi, M. S. (2019). Memoria en conflicto. Los incas en El Calvario de Fuerte Quemado de Yocavil, Noroeste Argentino.�Estudios Atacame�os (En l�nea), 62, 71-111
Clinical features and progression pattern of T790M+ compared with T790M-EGFR mutant NSCLC
No full textBaseline levels and dynamic changes of cfDNA, tumor fraction and mutations to anticipate the clinical course of small cell lung cancer (SCLC) patients treated with first-line atezolizumab and chemotherapy: an hypothesis generating study (CATS/ML43257)
No full textBackground: Atezolizumab (A) plus carboplatin-etoposide (CE) represents the new first-line treatment in extensive stage (ES)-Small Cell Lung Cancer (SCLC) patients. This study aims at identifying the association of baseline and dynamic changes of cfDNA, Tumor Fraction (TF) and variant allele frequency (VAF) of tumor-related mutations with median (m) overall (OS) and progression free survival (PFS) in SCLC patients treated with ACE. Materials and methods: This is a single-center prospective exploratory study including treatment-naive ES-SCLC patients eligible to first-line ACE. Liquid biopsies were longitudinally collected at baseline (T0), after cycle 1 (T1) and 2 (T2), at disease progression (T3). cfDNA Next Generation Sequencing (NGS) analysis was performed; genomic profiles and TF were inferred from shallow WGS (sWGS). Results: Thirty-two patients were included; mPFS and mOS were 5.19 and 7.96 months, respectively. Higher T0 cfDNA (HR 1.44, 95% CI 1.17-1.77, p = 0.0006) and VAF (HR 2.6, 95% CI 1.36-4.93, p = 0.0039) were associated with risk of death; higher T0 cfDNA (HR 1.29, 95% CI 1.08-1.54, p = 0.0049), TF (HR 1.97, 95% CI 1.02-3.82, p = 0.044) and VAF (HR 2.32, 95% CI 1.22-4.42, p = 0.01) were predictors of risk of PD. Among the dynamic changes in the biomarkers under investigation, the association of 10-unit increase of VAF T0-T1 and T0-T2 with OS (HR 1.38, 95% CI 1.01-1.88, p = 0.043; HR 1.56, 95% CI 1.21-2.16, p = 0.008) and PFS (HR 1.69, 95% CI 1.18-2.43, p = 0.004; HR 1.81, 95% CI 1.22-2.70, p = 0.003) was estimated. Conclusion: T0 and dynamic changes of cfDNA, TF and VAF may help physicians to stratify ES-SCLC patients receiving first-line ACE and to anticipate the clinical course of the disease
To be used in the kitchen. Acquisition, production and use of lithic artifacts in Structure 1 of Cardonal (Cajon Valley, Catamarca)
No full textFil: Sentinelli, Natalia. Universidad Nacional de Catamarca. Escuela de Arqueolog�a; ArgentinaFil: Scattolin, Mar�a Cristina. Consejo Nacional de Investigaciones Cient�ficas y T�cnicas. Universidad de Buenos Aires. Instituto de las Culturas; ArgentinaEn este trabajo se propone la reconstrucci�n de las actividades de talla l�tica llevadas a cabo en la Estructura 1 del N�cleo 1 del sitio arqueol�gico Cardonal en el valle del Caj�n (Catamarca) a comienzos de la Era Cristiana. El estudio de este recinto, interpretado como la cocina de la casa, permiti� analizar procesos tecnol�gicos microescalares para considerar el flujo de acciones t�cnicas incluidas en la realidad cotidiana de una vivienda. Aqu� se eval�a la elecci�n de recursos l�ticos por parte de los residentes en la casa, se estudia la variabilidad artefactual en el conjunto l�tico recuperado y se identifican las actividades tecnol�gicas l�ticas ocurridas en esta habitaci�n. La metodolog�a aplicada y los resultados obtenidos permitieron determinar la diversidad de rocas utilizadas, como tambi�n reconstruir una extensa gama de actividades de producci�n l�tica. Se entiende a la tecnolog�a l�tica como inmersa en las pr�cticas cotidianas en el marco de redes de relaciones que comprend�an no s�lo a otros habitantes de Cardonal, sino tambi�n a personas y paisajes distantes.This paper presents the reconstruction of lithic knapping activities carried out within Structure 1 of Compound 1 in the Cardonal archaeological site (Caj�n Valley, Catamarca) at the beginning of the Christian Era. The study of this structure, interpreted as the house kitchen, allowed us to analyze microscale technological processes, and so address the sum of technical actions that constituted daily life within the house. We evaluated the selection of lithic resources chosen by the inhabitants of the house and studied artifact variability within the lithic assemblage recovered, thereby identifying the lithic technological activities that occurred in the room. The methodology employed and the results obtained allowed us to determine the diversity of rocks used, as well as to reconstruct a wide range of lithic production activities. We focused on lithic technology embedded in everyday practices within network frameworks that included not only other Cardonal residents, but also more distant people and landscapes.Sentinelli, N. y Scattolin, M. C. (2019). Para usar en la cocina. Adquisici�n, producci�n y uso de artefactos l�ticos en la Estructura 1 de Cardonal (Valle del Caj�n, Catamarca).�Arqueolog�a,�25(1), 69-93
Arab-West Report Papers 2007 - 2016
No full textThe dataset contains papers written between 2007 and 2016 by researchers and interns at the Center for Arab-West Understanding ( CAWU) in Cairo or by researchers and academics connected to CAWU. The papers aim at obtaining a better understanding of the role of religion in society, including:- Relations between Muslims and Christians in Egypt;- Problems around church building, the highly controversial topic of (alleged) kidnappings of Christian youth, claims of forced conversions, reports on sectarian incidents in Egypt and media critique to uncover biased reporting within Egypt as well as the stereotypical tone in Western media;- The role of Christian and Muslim institutions in society and the political sphere;- Activities of human rights organizations;- Islam and politics.All papers are:- Descriptive and take different points of views serious as part of the description of events unfolding in society;- Contributing to a better understanding of people between different cultures and beliefs.Methodology:Papers always include Egyptian source material. Authors were recommended to make use of the AWR database, conduct interviews in Egypt and where encouraged to contrast results with western news coverage.Papers discuss one subject at length and were reviewed by Egyptian and/or Western academics, within the bounds of organizational possibility and edited by Cornelis Hulsman or others to guarantee academic standards. This has resulted in a number of unique studies about subjects that are rarely covered in depth elsewhere. These papers are completed texts but besides, additional texts from reviewers often include interesting suggestions for further research.With thanks to:Prentice (Author), P. (Center for Arab West Understanding (CAWU))Disouqi (Reviewer), Dr. R. (Azhar University)Wagieh (Author, Reviewer), Dr. H. (Azhar University)Fowler (Reviewer), Prof. Dr. M. (American University in Cairo (AUC))Hulsman (Author, Editor, Reviewer), Drs. C. (CAWU)Atmaca (Author), N. (CAWU)Anwar (Author), S. (CAWU)Bodman (Reviewer), Dr. (Assoc. Prof.) W. (Austin Seminary, Texas, USA)Richards-Benson (Language editor CIDT), C. (CAWU)Fastenrath (Author), C. (CAWU)Kazanjian (Author), C. (CAWU)Makram Ebeid (Reviewer), Dr. A. (CAWU)Snyder (Author), M. (CAWU)Aguzzoni (Author), S. (CAWU)Turner (Reviewer, Academic language editor CIDT), C.Holm (Author), M. (CAWU)Bredstrup (Author), M. (CAWU)Dokhan (Author), B. (CAWU)Marqus (Author), S. (CAWU)al-Ghanām (Author), A. (CAWU)Chetty (Author), J. (CAWU)Sayf ʿAllām (Author), R. (CAWU)Neubert (Author), S. (CAWU)Nielsen (Author), J.R. (CAWU)Wamboldt (Author), A. (CAWU)Connery (Author), B. (CAWU)Drouin (Author), R. (CAWU)Schep (Author), C. (CAWU)Roters (Author), D. (CAWU)van Baalen (Reviewer), J. (CIDT)Casper (Author, Reviewer), J. (CAWU)Curtis (Author), R. (CAWU)al-Ashāl (Author), M. (CAWU)Labīb (Author), A. (CAWU)Gabra (Reviewer, Supervisor), Eng. S. (CAWU)Fawzy (Reviewer), S.Magdy (Author), M. (CAWU)Justesen (Author), E. (CAWU)Adeh (Author), D. (CAWU)Fuʿād (Author), S. (CAWU)Edwards (Author), E. (CAWU)Marshall (Author), C. D. (CAWU)Yaḥyā (Author), L. (CAWU)Ferrecchia (Author, Language editor), J. (CAWU /CIDT)Gallo (Language-editor), W. (CIDT)Lundberg, S. (Lund University)Mc Donell (Author), A. (CAWU)Khayyal (Reviewer, Editor), Prof. em. M.al-Zanātī (Author), F. (Cairo University)al-Ghazālī (Author), M. (CAWU)Salāmah (Author), U.Weißenfels (Author), A. (CAWU)Serôdio (Author), D. (CAWU)Messiha (Reviewer), Dr. G. (form. Constituent Assembly Parliament (Egypt))Talaat (Reviewer), Dr. A. (Supreme Court (Egypt))Schleiffer (Reviewer), Prof. em. A. (american University of Cairo (AUC))Paulus (Reviewer), Dr. C. (Al-Azhar University, Cairo)Slomp (Reviewer), Rev. Dr J. (International Advisory Board of the Journal of Muslim Minority Affairs (JMMA))Scattolin (Reviewer), Fr. Dr. G. (Dar Comboni, Cairo)Forster (Author), R.A.Fathina (Author), H. (CAWU)Schoorel (Author), E. (CAWU)Stacey (Language editor), E. (CIDT)Byeongsun, A. (CAWU)Weinert (Author), F. (CAWU)Gillé (Reviewer, Editor), M.Jongeneel, Prof. em. J. (Utrecht University)Fargues, Prof. Dr. P. (American University Cairo (AUC))Middelstaed-Rizkallah (Author), J. (CIDT)Coffee (Author, Editor, Reviewer), J. (CAWU / CIDT)Atallah (Reviewer), R. (Egyptian Bible Society)Jørgensen (Reviewer), Prof. Dr. K. (Aarhus University)Suermann (Reviewer), Prof. Dr. H. (University of Bonn)Gajan (Author,Reviewer), M. (CAWU)Volkmann (Author, Reviewer), E. (CAWU)Mūsah Jamaʿa (Author), A. (CAWU)Amelia (Author), D. (CAWU)Gajan (Author), S. (CAWU)</p
- …
